Mefruside: a preliminary report of its pharmacological properties and therapeutic efficacy in oedema and hypertension.
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004487:Edema / Q000188:drug therapy*; D005260:Female; D005663:Furans / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007003:Hypoglycemia / Q000139:chemically induced; D007668:Kidney / Q000378:metabolism; D008138:Loop of Henle / Q000187:drug effects; D008875:Middle Aged; D009318:Natriuresis / Q000187:drug effects; D011188:Potassium / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D013449:Sulfonamides; D014527:Uric Acid / Q000378:metabolism
D000959:Antihypertensive Agents; D004232:Diuretics; D005663:Furans; D013449:Sulfonamides; D014527:Uric Acid; D011188:Potassium